Establishment Net Income Applicable To Common Shares from 2010 to 2024
| ESTA Stock | USD 52.15 0.41 0.79% |
Net Loss | First Reported 2016-12-31 | Previous Quarter -11.9 M | Current Value -16.7 M | Quarterly Volatility 8.3 M |
Check Establishment Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Establishment main balance sheet or income statement drivers, such as Interest Income of 568 K, Interest Expense of 9.4 M or Selling General Administrative of 74 M, as well as many exotic indicators such as Price To Sales Ratio of 3.81, Dividend Yield of 0.0026 or PTB Ratio of 37.83. Establishment financial statements analysis is a perfect complement when working with Establishment Labs Valuation or Volatility modules.
Establishment | Net Income Applicable To Common Shares |
Latest Establishment Labs' Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Establishment Labs Holdings over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Establishment Labs' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Establishment Labs' overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Establishment Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | (27,488,586) | |
| Coefficient Of Variation | (96.29) | |
| Mean Deviation | 22,278,359 | |
| Median | (22,159,000) | |
| Standard Deviation | 26,469,585 | |
| Sample Variance | 700.6T | |
| Range | 73.6M | |
| R-Value | (0.93) | |
| Mean Square Error | 100.1T | |
| R-Squared | 0.87 | |
| Slope | (5,512,212) | |
| Total Sum of Squares | 9808.9T |
Establishment Net Income Applicable To Common Shares History
About Establishment Labs Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Establishment Labs income statement, its balance sheet, and the statement of cash flows. Establishment Labs investors use historical funamental indicators, such as Establishment Labs's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Establishment Labs investors may use each financial statement separately, they are all related. The changes in Establishment Labs's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Establishment Labs's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Establishment Labs Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Establishment Labs. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -67.7 M | -64.3 M |
Pair Trading with Establishment Labs
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Establishment Labs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Establishment Labs will appreciate offsetting losses from the drop in the long position's value.Moving against Establishment Stock
| 0.91 | MMSI | Merit Medical Systems Financial Report 24th of April 2024 | PairCorr |
| 0.87 | LUCY | Innovative Eyewear | PairCorr |
| 0.86 | INNV | InnovAge Holding Corp Financial Report 14th of May 2024 | PairCorr |
| 0.85 | FIGS | Figs Inc Financial Report 2nd of May 2024 | PairCorr |
| 0.77 | AGL | agilon health Upward Rally | PairCorr |
The ability to find closely correlated positions to Establishment Labs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Establishment Labs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Establishment Labs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Establishment Labs Holdings to buy it.
The correlation of Establishment Labs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Establishment Labs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Establishment Labs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Establishment Labs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Establishment Labs Correlation against competitors. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Establishment Stock analysis
When running Establishment Labs' price analysis, check to measure Establishment Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Establishment Labs is operating at the current time. Most of Establishment Labs' value examination focuses on studying past and present price action to predict the probability of Establishment Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Establishment Labs' price. Additionally, you may evaluate how the addition of Establishment Labs to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is Establishment Labs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. If investors know Establishment will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Establishment Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.07) | Revenue Per Share 6.451 | Quarterly Revenue Growth (0.28) | Return On Assets (0.17) | Return On Equity (15.38) |
The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Establishment Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Establishment Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Establishment Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.